Analytical strategies for the characterization of therapeutic monoclonal antibodies

被引:109
|
作者
Fekete, Szabolcs [1 ]
Gassner, Anne-Laure [1 ]
Rudaz, Serge [1 ]
Schappler, Julie [1 ]
Guillarme, Davy [1 ]
机构
[1] Univ Lausanne, Sch Pharmaceut Sci, Univ Geneva, CH-1211 Geneva 4, Switzerland
关键词
Adsorption; Analytical strategy; Capillary electrophoresis (CE); Characterization; Liquid chromatography (LC); Mass spectrometry; Monoclonal antibody (mAb); Recombinant; Separation; Therapeutic monoclonal antibody; CAPILLARY GEL-ELECTROPHORESIS; LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY; CHARGE HETEROGENEITY; POSTTRANSLATIONAL MODIFICATIONS; FLUORESCENCE DETECTION; MASS-SPECTROMETRY; QUALITY-CONTROL; CE; VALIDATION; PROTEINS;
D O I
10.1016/j.trac.2012.09.012
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Recombinant monoclonal antibodies (mAbs) have become particularly relevant for the treatment of autoimmune diseases or cancers. Because of their inherent complexity and for safety reasons, there is a need to develop powerful analytical methods to provide detailed characterizations of mAbs. The aim of the present review is to detail the state-of-the-art of analytical strategies for mAb characterization. It focuses on the most important separation techniques used in this field, specifically, the chromatographic and electrophoretic approaches and their combination with mass spectrometry (MS). Thanks to recent improvements in separation science and MS devices, mAbs can be analyzed more easily. However, there is still a need to find new approaches that avoid adsorption issues. (c) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:74 / 83
页数:10
相关论文
共 50 条
  • [21] The development and characterization of anti-cancer therapeutic monoclonal antibodies
    Duan, X
    Gajewczyk, D
    Uger, MD
    Cechetto, L
    Ding, X
    McConkey, F
    Hitzler, JD
    Groves, T
    Young, D
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 444 - 444
  • [22] A generic workflow for the characterization of therapeutic monoclonal antibodies—application to daratumumab
    Bastiaan L. Duivelshof
    Szabolcs Fekete
    Davy Guillarme
    Valentina D’Atri
    Analytical and Bioanalytical Chemistry, 2019, 411 : 4615 - 4627
  • [23] Monoclonal Antibodies and Biosimilars - A Selection of Analytical Tools for Characterization and Comparability Assessment
    Sandra, Koen
    Vandenheede, Isabel
    Dumont, Emmie
    Sandra, Pat
    LC GC EUROPE, 2015, : 16 - 23
  • [24] Therapeutic use of monoclonal antibodies
    Baron, D
    NATURWISSENSCHAFTEN, 1997, 84 (05) : 189 - 198
  • [25] Therapeutic use of monoclonal antibodies
    Garcia Ramos, S. E.
    Garcia Poza, P.
    Ramos Diaz, F.
    ARS PHARMACEUTICA, 2011, 52 (03) : 46 - 57
  • [26] Safety of Therapeutic Monoclonal Antibodies
    Niebecker, Ronald
    Kloft, Charlotte
    CURRENT DRUG SAFETY, 2010, 5 (04) : 275 - 286
  • [27] Therapeutic monoclonal antibodies in oncology
    Bouzid, K.
    Bedairia, N.
    Marty, M.
    PATHOLOGIE BIOLOGIE, 2012, 60 (04): : 223 - 228
  • [28] Engineering therapeutic monoclonal antibodies
    Liu, Xiao-yun
    Pop, Laurentiu M.
    Vitetta, Ellen S.
    IMMUNOLOGICAL REVIEWS, 2008, 222 : 9 - 27
  • [29] Therapeutic monoclonal antibodies in ophthalmology
    Rodrigues, Eduardo B.
    Farah, Michel E.
    Maia, Mauricio
    Penha, Fernando M.
    Regatieri, Caio
    Melo, Gustavo B.
    Pinheiro, Marcelo M.
    Zanetti, Carlos R.
    PROGRESS IN RETINAL AND EYE RESEARCH, 2009, 28 (02) : 117 - 144
  • [30] Purifying therapeutic monoclonal antibodies
    Mehta, Amit
    Tse, Martha Lovato
    Fogle, Jace
    Len, Amy
    Shrestha, Roshan
    Fontes, Nuno
    Lebreton, Benedicte
    Wolk, Bradley
    van Reis, Robert
    CHEMICAL ENGINEERING PROGRESS, 2008, 104 (05) : S14 - S20